HUMA vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

HUMA

36.6
AI Score
VS
HUMA Wins

CLYM

31.0
AI Score

Investment Advisor Scores

HUMA

37score
Recommendation
SELL

CLYM

31score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HUMA CLYM Winner
Net Income -40.83M -41.79M HUMA
Operating Income -108.14M -47.46M CLYM
ROE -1313.4% -18.3% CLYM
ROA -35.1% -17.7% CLYM
Total Assets 116.37M 236.56M CLYM
Cash 50.50M 39.73M HUMA
Current Ratio 3.69 26.58 CLYM
Free Cash Flow -105.93M -38.01M CLYM

Relative Price Performance (Last 90 Days)

HUMA 1M: +27.1% · 3M: -0.4% CLYM 1M: -5.0% · 3M: -40.6%

Current Technical Phase

HUMA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.4 · Price: $0.56

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.6 · Price: $10.36

Fundamentals Snapshot

Metric HUMA CLYM
Market Cap — —
Forward P/E -2.1 -10.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.4% 0.0%
Gross Margin -10.6% —
Operating Margin -45.7% 0.0%
EPS -0.45 -0.81
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HUMA is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.